Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2022 Sep 20;454:116250. doi: 10.1016/j.taap.2022.116250

Figure 1.

Figure 1.

Chemotypes significantly enriched in compounds active for DILI. Chemotypes are sorted by significance based on p-values. Representative drugs that contain these structural fragments are displayed with significant chemotypes highlighted in red.